We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£495.00
The 2013-2018 Outlook for Renal Cell Carcinoma (RCC) Drugs in the United States
Price data last checked 39 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 52 days · 52 data points (no recent data)
Price Distribution
Price distribution over 52 days • 1 price levels
Price Analysis
Most common price: £495 (52 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 52 days
Product Specifications
- Format
- paperback
- ASIN
- B00E0XFF6M
- Domain
- Amazon UK
- Release Date
- 17 July 2013
- Listed Since
- 23 July 2013
Similar Products You Might Like
The 2023-2028 Outlook for Kidney Cancer Drugs in the United States
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
Clear Cell Renal Cell Carcinoma 2021-2022
The 2023-2028 Outlook for End Stage Renal Diseases in the United States
The 2023-2028 Outlook for Kidney /Renal Function Tests in the United States
The 2023-2028 Outlook for Cancer Screenings in the United States
Renal Cell Carcinoma: Research and Treatments
Foster Academics
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
The 2023-2028 Outlook for Kidney /Renal Function Tests in India
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Asia
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
Renal Cell Carcinoma
IntechOpen
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
The 2023-2028 Outlook for Cancer Screenings in China
Renal Cancer: Old and New Paradigms, An Issue of Urologic Clinics: Volume 50-2 (The Clinics: Surgery, Volume 50-2)
Elsevier
The 2023-2028 Outlook for Cancer Supportive Care in the United States
The 2023-2028 Outlook for Kidney /Renal Function Tests in China
Kidney cancer (renal cell carcinoma): A survival guide for patients
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East
The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan
The 2023-2028 Outlook for Cancer Screenings in Japan
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
